Market Insight Drug Discovery |

Accelerating Hit Identification with AI

Steffen Renner

Steffen Renner

Associate Director Data Science

Novartis

12 August, 2026
Watch time: 18 Minutes

Highlights

Takeaways

We present practical applications of AI-driven strategies for hit identification, including virtual screening, make-on-demand library mining, compound prioritization, and exploitation of data-rich screening decks, alongside iterative screening workflows and automated hit expansion.

Steffen Renner, Associate Director Data Science, Novartis

PREMIUM CONTENT

Want that extra level of detail?
Subscribe and get access to full length presentations and write-ups giving you the insights to stay ahead of the curve.

Please note once we have received payment it can take 24 hours for your account to be updated to the premium access.